Artificial intelligence generated plenty of chatter amongst the pharma marketing intelligentsia in 2018. Will 2019 be the year when the industry fully embraces it as more than just a tactic?
Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in U.S. deaths from overdoses.
A combination of regulatory conditions, shifts in physician workplace demographics, and an increased reliance of highly specialized sales personnel has steadily eroded the traditional sales reps’ responsibilities and ability to manage the HCP practice relationship as a true SPOC.
The House of Reps is expected to pass a $6.3 billion piece of legislation designed to spur medical innovation, speed access to new drugs, expand mental health treatment, and combat opioid abuse.
The CHC’s mission is to promote and protect the benefit, for society and individual patient care, of the free flow of healthcare information.